← Eichor
Study identifier: NCT04084938 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Artery Embolization vs Operation of Benign Prostate Hyperplasia

Condition: Benign Prostatic Hyperplasia · Post-Op Complication · Embolization Therapeutic  ·  Sponsor: Oslo University Hospital

PhaseNA
Planned participants140
Who can joinMale, N/A to no upper limit
Healthy volunteersNo

About this study

Aim of the study is to compare prostate artery embolization (PAE) to the established surgical treatment for patient acceptance, morbidity, complications, and the functional outcomes. To compare length of stay, hospital costs and time for recovery. 140 patients will be randomized to PAE or surgery. Patients should suffer from lower urinary tract symptoms (LUTS), be candidates for both treatments and willing to undergo both procedures. Before randomization computed tomography angiography of the pelvic arteries is done to select eligible patients. Magnetic resonance imaging of prostate rules out possible cancer. The PAE is done in the angio suite in the radiology department injecting small particles into the prostate arteries. The surgery is done in the operation room in the urology department according to established procedures. Clinical follow-up include clinical visit after 3 months, 1 and 5 years. Acute as well as long term complications will be recorded.

This description comes directly from the study's public registry record.

Talk to the study team

Thijs Hagen, MD  ·  + 47 45002349  ·  thihag@ous-hf.no

Eduard Baco, MD, PHD  ·  +47 95221378  ·  eduaba@online.no

Always discuss trial participation with your own doctor first.

Locations (1)

Oslo University Hospital, AkerOslo, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04084938